This blend combines CJC-1295 without DAC (Drug Affinity Complex), a synthetic analogue of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue receptor (GHSR) agonist. The two peptides act through complementary mechanisms — CJC-1295 amplifies the pulsatile release pattern while Ipamorelin selectively stimulates GH release without significant effect on cortisol or prolactin. This combination has been widely studied in GH axis research. Each vial contains a pre-measured 5mg blend (2.5mg CJC-1295 / 2.5mg Ipamorelin), independently verified by HPLC-MS.
For Research Use Only. This product is not intended for human or veterinary use, diagnostic, or therapeutic purposes. It must not be used as a food, drug, or cosmetic. By adding to cart you confirm you are a qualified researcher using this product in compliance with all applicable laws.
Secure checkout with Cash App, Zelle, or Bitcoin.
All products for research use only.